Introduction

This page provides a comprehensive analysis of the known insider trading history of Adam H Schechter. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Adam H Schechter has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:DVA / DaVita Inc. Director 4,699
US:LH / Labcorp Holdings Inc. President & CEO, Director 93,319
US:MRK / Merck & Co., Inc. EVP & Pres-Global Human Health 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Adam H Schechter. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Adam H Schechter as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-19 2025-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 369 4,699 8.52
2025-08-13 2025-08-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -5,643 93,319 -5.70 266.78 -1,505,440 24,895,643
2025-05-16 2025-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 348 4,330 8.74
2025-05-13 2025-05-12 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,105 98,962 -5.81 248.73 -1,518,497 24,614,818
2025-03-31 2025-03-27 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -13,584 105,067 -11.45 231.67 -3,147,005 24,340,872
2025-03-31 2025-03-27 4 LH LABCORP HOLDINGS INC.
Common Stock
A - Award 30,469 118,651 34.55
2025-03-18 2025-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 349 3,982 9.61
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,226 88,182 -1.37 245.14 -300,542 21,616,935
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 2,963 89,408 3.43
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,121 86,445 -6.61 244.62 -1,497,319 21,146,176
2025-02-10 2025-02-07 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,345 92,566 -1.43 246.27 -331,233 22,796,229
2025-02-10 2025-02-07 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 3,250 93,911 3.58
2025-02-10 2025-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,240 90,661 -1.35 247.74 -307,198 22,460,356
2025-02-10 2025-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 4,460 91,901 5.10
2024-11-19 2024-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 312 3,633 9.39
2024-11-13 2024-11-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,189 87,441 -6.61 243.47 -1,506,836 21,289,260
2024-08-19 2024-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 333 3,321 11.14
2024-05-17 2024-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 363 2,988 13.83
2024-03-29 2024-03-27 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -31,799 93,630 -25.35 216.57 -6,886,709 20,277,449
2024-03-29 2024-03-27 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 72,435 125,429 136.69
2024-03-19 2024-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 366 2,625 16.20
2024-02-13 2024-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,231 52,994 -2.27 227.45 -279,991 12,053,485
2024-02-13 2024-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,964 54,225 5.78
2024-02-08 2024-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,149 51,261 -2.19 223.71 -257,043 11,467,598
2024-02-08 2024-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,250 52,410 6.61
2024-02-06 2024-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -822 49,160 -1.64 221.54 -182,106 10,890,906
2024-02-06 2024-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,094 49,982 6.60
2023-11-17 2023-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 529 2,259 30.58
2023-08-17 2023-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 475 1,730 37.85
2023-05-17 2023-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 516 1,255 69.82
2023-04-03 2023-03-30 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -18,646 46,888 -28.45 224.70 -4,189,756 10,535,734
2023-04-03 2023-03-30 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 42,353 65,534 182.71
2023-03-17 2023-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 658 739 812.35
2023-02-14 2023-02-13 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,170 23,181 -4.80 248.13 -290,312 5,751,902
2023-02-14 2023-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,656 24,351 12.24
2023-02-07 2023-02-06 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,368 21,695 -5.93 244.50 -334,476 5,304,428
2023-02-07 2023-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,507 23,063 17.93
2023-02-06 2023-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -805 19,556 -3.95 254.99 -205,267 4,986,584
2023-02-06 2023-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,773 20,361 15.77
2022-11-16 2022-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 81 81
2022-11-03 2022-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -893 17,588 -4.83 222.56 -198,746 3,914,385
2022-11-03 2022-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,007 18,481 12.18
2022-09-29 3 DVA DAVITA INC.
No securities are beneficially owned
0
2022-02-15 2022-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 28,100 28,100
2022-02-15 2022-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 7,970 19,031 72.05
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -3,507 11,061 -24.07
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,412 16,474 -7.89 277.48 -391,802 4,571,206
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,507 17,886 24.39
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,773 14,568 -15.99
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -803 14,379 -5.29 273.18 -219,364 3,928,055
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,773 15,182 22.35
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,007 17,341 -10.37
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -886 12,409 -6.66 288.78 -255,859 3,583,471
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,007 13,295 17.78
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -3,506 19,348 -15.34
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,028 11,288 -8.35 223.78 -230,046 2,526,029
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,506 12,316 39.80
2021-02-04 2021-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 29,000 29,000
2021-02-04 2021-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 8,320 22,854 57.25
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,006 14,534 -12.13
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -885 8,810 -9.13 207.23 -183,399 1,825,696
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,006 9,695 26.09
2020-02-14 2020-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,227 16,540 -6.91
2020-02-14 2020-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,227 7,689 18.99
2020-02-06 2020-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 45,600 45,600
2020-02-06 2020-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 10,520 17,767 145.16
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 65,100 65,100
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 24,800 24,800
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 6,020 7,247 490.63
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,227 1,227
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,038 0 -100.00
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,038 6,462 19.14
2019-02-14 2018-11-19 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
G - Gift -610 5,424 -10.11
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -277,879 0 -100.00
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -145,135 0 -100.00 73.66 -10,691,181
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -132,744 145,135 -47.77 73.98 -9,819,764 10,736,391
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 277,879 277,879 39.29 10,917,866 10,917,866
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -100,000 0 -100.00
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -7,360 55,406 -11.73 70.18 -516,511 3,888,286
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -100,000 0 -100.00 70.18 -7,017,780
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 100,000 100,000 36.56 3,656,000 3,656,000
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -100,000 100,000 -50.00
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -34,094 62,766 -35.20 61.00 -2,079,785 3,828,819
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -100,000 0 -100.00 61.00 -6,100,160
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 100,000 100,000 36.56 3,656,000 3,656,000
2018-05-08 2018-05-04 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 139,063 139,063
2018-03-01 2018-02-27 4 MRK Merck & Co., Inc.
Common Stock
A - Award 34,094 34,094 54.72 1,865,624 1,865,624
2018-02-14 2018-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,038 1,038
2018-02-09 2018-02-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
S - Sale X -1,263 6,034 -17.31 169.29 -213,813 1,021,496
2018-02-09 2018-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,263 0 -100.00
2018-02-09 2018-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,263 7,297 20.93
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,994 200,000 -20.32
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,608 62,766 -44.64 61.63 -3,118,971 3,868,267
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,994 0 -100.00 61.63 -3,142,760
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,994 50,994 36.56 1,864,341 1,864,341
2017-12-18 2017-12-15 4 MRK Merck & Co., Inc.
Common Stock
G - Gift -750 113,374 -0.66
2017-05-09 2017-05-05 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 162,625 162,625
2017-04-10 2017-02-27 4/A MRK Merck & Co., Inc.
Common Stock
A - Award 37,758 37,758 65.85 2,486,364 2,486,364
2017-04-04 2017-04-03 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -53,850 116,336 -31.64 63.48 -3,418,166 7,384,507
2017-03-01 2017-02-27 4 MRK Merck & Co., Inc.
Common Stock
A - Award 39,970 39,970 65.85 2,632,024 2,632,024
2017-02-13 2017-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,560 1,263 -55.26
2017-02-13 2017-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,560 6,034 34.87
2017-02-09 2017-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,263 2,823 80.96
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -26,135 0 -100.00
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -10,200 250,994 -3.91
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -36,335 0 -100.00 63.73 -2,315,699
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 10,200 36,335 39.03 36.56 372,912 1,328,408
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 26,135 26,135 33.49 875,261 875,261
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -39,200 26,135 -60.00
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -39,200 0 -100.00 62.61 -2,454,308
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 39,200 39,200 33.49 1,312,808 1,312,808
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,000 0 -100.00 57.69 -2,884,415
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,000 50,000 44.30 2,215,000 2,215,000
2016-05-12 2016-05-10 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 258,065 258,065
2016-03-15 2016-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,237 1,560 -44.23
2016-03-15 2016-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,237 4,474 38.21
2016-02-24 2016-02-22 4 MRK Merck & Co., Inc.
Common Stock
A - Award 37,223 37,223 50.77 1,889,812 1,889,812
2016-02-11 2016-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,560 2,797 126.11
2015-05-11 2015-05-11 4 MRK Merck & Co., Inc.
Common Stock
S - Sale -10,634 0 -100.00 60.44 -642,768
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Restricted Stock Unit
M - Exercise -19,343 0 -100.00 59.86 -1,157,872
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Common Stock
F - Taxes -8,709 10,634 -45.02 59.86 -521,321 636,551
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 19,343 19,343
2015-05-05 2015-05-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 235,294 235,294
2015-03-13 2015-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,237 1,237
2015-02-25 2015-02-23 4 MRK Merck & Co., Inc.
Common Stock
A - Award 22,198 22,198 58.30 1,294,143 1,294,143
2015-02-12 2015-02-10 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,503 0 -100.00
2015-02-12 2015-02-10 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,503 3,237 86.68
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -19,200 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -74,200 0 -100.00 62.48 -4,636,224
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 74,200 7.23 34.47 172,350 2,557,674
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 19,200 69,200 38.40 35.09 673,728 2,428,228
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,000 50,000 44.19 2,209,500 2,209,500
2014-11-25 2014-11-24 4 MRK Merck & Co. Inc.
Phantom Stock
S - Sale -2,779 0 -100.00
2014-08-25 2014-08-25 4 MRK Merck & Co. Inc.
Common Stock
S - Sale X -22,000 70,795 -23.71 59.70 -1,313,380 4,226,396
2014-05-15 2014-05-13 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,503 1,503
2014-05-14 2014-05-14 4 MRK Merck & Co. Inc.
Common Stock
S - Sale X -10,527 0 -100.00 55.91 -588,584
2014-05-13 2014-05-09 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 209,078 209,078
2014-05-12 2014-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,593 0 -100.00
2014-05-12 2014-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,593 1,734 1,129.79 98.96 157,643 171,597
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -19,147 0 -100.00 58.22 -1,114,738
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -8,620 10,527 -45.02 58.22 -501,856 612,882
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 19,147 19,147
2014-02-26 2014-02-24 4 MRK Merck & Co. Inc.
Common Stock
A - Award 22,287 22,287 56.18 1,252,084 1,252,084
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -3,000 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -2,500 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -12,500 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock - 401(k) Plan
I - Other -4,040 0 -100.00 55.70 -225,049
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
S - Sale -18,000 0 -100.00 55.61 -1,000,935
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 2,500 18,000 16.13 47.39 118,475 853,020
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 3,000 15,500 24.00 45.41 136,230 703,855
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 12,500 12,500 48.24 603,000 603,000
2013-05-16 2013-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,593 1,593
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -12,188 0 -100.00 44.98 -548,216
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -5,488 22,416 -19.67 44.98 -246,850 1,008,252
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 12,188 27,904 77.55
2013-05-08 2013-05-06 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 244,767 244,767
2013-04-03 2013-04-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 141 141
2013-02-27 2013-02-25 4 MRK Merck & Co. Inc.
Common Stock
A - Award 8,136 15,568 109.47 42.52 345,943 661,951
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -10,670 0 -100.00 41.42 -441,951
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -3,238 7,432 -30.35 41.42 -134,118 307,833
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 10,670 10,670
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -61,200 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
S - Sale -56,300 14,900 -79.07 45.60 -2,567,257 679,434
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 5,000 71,200 7.55 28.42 142,100 2,023,504
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 5,000 66,200 8.17 31.84 159,200 2,107,808
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 61,200 61,200 23.45 1,435,140 1,435,140
2012-05-04 2012-05-02 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 277,879 277,879
2012-05-04 2012-05-02 4 MRK Merck & Co. Inc.
Restricted Stock Unit
A - Award 19,343 19,343
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -11,475 0 -100.00 38.27 -439,148
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -4,535 7,035 -39.20 38.27 -173,554 269,226
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 11,475 11,570 12,089.51
2012-03-01 2012-02-28 4 MRK Merck & Co. Inc.
Common Stock
A - Award 9,194 9,194 38.38 352,866 352,866
2010-05-06 3 MRK Merck & Co. Inc.
Common Stock - 401(k) Plan
9,804
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)